Biocon

Market Cap

40,340.16 Cr

EPS

8.55

PE Ratio

52.28

Dividend Yield

0.15 %

Industry

Healthcare

52 Week High

404.70

52 Week low

244.55

PB Ratio

1.93

Debt to Equity

0.91

Sector

Pharmaceuticals

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Analyst Rating

- By Refinitiv from15 analysts

Analysts have suggested that investors can buy this stock

Buy60.00 %

60.00 %

Hold20.00 %

20.00 %

Sell20.00 %

20.00 %

Company News

View All News

European Commission Approves Biocon Biologics' Ustekinumab Biosimilar2 days ago

The European Commission has granted approval for Biocon Biologics' ustekinumab biosimilar. This approval marks a significant milestone for the company in the European pharmaceutical market, potentially expanding their product offerings and market reach.

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,669.30	4,00,520.99	34.13	49,887.20	12.06	9,648	13.77	37.74
Divis Laboratories	5,978.30	1,58,705.08	76.14	8,184.00	0.89	1,600	64.53	51.57
Cipla	1,479.70	1,19,502.65	23.70	26,520.70	14.17	4,155	47.38	51.15
Torrent Pharmaceuticals	3,095.95	1,04,781.02	56.64	10,785.70	11.59	1,656	13.54	45.77
Dr Reddys Laboratories	1,170.95	97,705.34	18.09	28,905.40	12.36	5,578	1.69	30.83
Mankind Pharma	2,348.45	96,889.27	47.77	10,615.60	19.57	1,942	-16.38	39.42
Zydus Life Science	899.65	90,525.84	19.78	19,831.50	13.82	3,831	29.92	36.77
Lupin	1,977.50	90,213.07	31.46	20,141.50	19.94	1,936	38.82	38.83
Aurobindo Pharma	1,121.25	65,122.38	18.72	29,559.20	17.55	3,169	-10.04	42.81
Abbott	29,429.65	62,535.95	47.37	6,097.20	10.80	1,201	16.01	61.56

Growth Rate

Revenue Growth

35.25 %

Net Income Growth

101.84 %

Cash Flow Change

59.45 %

ROE

79.37 %

ROCE

103.31 %

EBITDA Margin (Avg.)

6.64 %

Quarterly Financial Results

Quarterly Financials	Mar 2015	Jun 2015	Sept 2015	Dec 2015	Mar 2016	Jun 2016	Sept 2016	Dec 2016	Mar 2017	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024
Revenue	952	778	800	811	1,223	1,029	989	1,086	974	986	1,025	1,098	1,242	1,193	1,564	1,585	1,557	1,483	1,673	1,784	1,621	1,712	1,765	1,885	2,060	1,808	1,945	2,223	2,476	2,217	2,384	3,020	3,929	3,516	3,551	4,135	3,966	4,543	3,604	3,826
Expenses	653	606	727	615	740	719	706	762	738	735	786	836	937	886	982	1,160	1,137	1,029	1,174	1,307	1,247	1,284	1,363	1,459	1,476	1,427	1,515	1,733	1,911	1,783	1,894	2,624	2,820	2,741	2,769	3,051	3,013	2,813	2,905	3,070
EBITDA	300	172	73	196	483	309	283	324	236	250	239	262	306	307	582	425	420	454	499	477	373	428	402	427	584	380	430	489	565	434	490	396	1,109	775	782	1,084	953	1,730	699	756
Operating Profit %	21 %	20 %	6 %	22 %	21 %	27 %	25 %	27 %	20 %	21 %	19 %	21 %	20 %	21 %	26 %	25 %	26 %	29 %	25 %	25 %	20 %	24 %	22 %	21 %	20 %	19 %	18 %	20 %	21 %	17 %	18 %	11 %	25 %	20 %	18 %	14 %	23 %	17 %	18 %	19 %
Depreciation	59	59	61	64	65	66	68	70	73	99	94	97	95	99	112	117	120	124	132	144	152	167	178	186	184	195	202	206	212	218	231	301	364	358	389	415	407	405	420	425
Interest	0	4	3	2	21	6	7	9	5	16	14	15	17	18	19	19	16	17	14	18	17	13	7	5	34	20	23	15	11	20	30	120	249	233	248	267	227	236	226	223
Profit Before Tax	249	165	20	141	409	238	208	245	159	135	132	150	193	190	451	289	284	313	354	315	204	249	218	236	366	166	206	269	343	197	229	-26	497	184	214	808	319	1,146	98	156
Tax	32	34	18	19	55	55	42	54	10	38	43	36	41	52	73	46	41	85	100	85	45	81	22	49	69	57	46	49	59	30	147	-5	82	35	42	55	96	284	71	75
Net Profit	217	131	2	122	354	182	167	191	148	98	89	114	153	138	378	243	243	228	254	230	159	168	195	187	296	108	160	220	284	167	82	-21	415	149	173	753	223	862	27	81
EPS in ₹	10.08	6.31	-0.54	5.30	16.97	8.49	7.48	8.72	6.49	1.38	1.17	1.56	2.21	1.02	3.00	3.67	3.61	1.74	1.82	1.71	1.04	1.26	1.39	1.42	2.13	0.71	1.16	1.57	2.00	1.21	0.39	-0.35	2.62	0.85	1.05	5.52	1.13	5.51	-0.13	0.21

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	6,375	8,458	9,394	9,990	12,192	14,444	18,522	20,394	52,043	56,071
Fixed Assets	1,630	1,749	3,626	3,700	4,471	5,971	6,364	6,569	29,468	30,644
Current Assets	2,563	3,971	4,048	4,149	4,889	5,325	7,600	8,382	12,334	15,179
Capital Work in Progress	1,677	2,240	839	1,303	1,899	2,196	2,800	4,110	7,317	7,993
Investments	230	901	1,253	675	1,012	966	1,952	1,588	2,069	1,000
Other Assets	2,839	3,569	3,676	4,312	4,811	5,311	7,406	8,127	13,189	16,434
Total Liabilities	6,375	8,458	9,394	9,990	12,192	14,444	18,522	20,394	52,043	56,071
Current Liabilities	1,555	1,666	1,678	2,141	3,039	4,008	4,210	3,828	8,511	15,359
Non Current Liabilities	1,378	2,493	2,502	2,200	2,447	3,053	5,805	7,096	21,043	15,437
Total Equity	3,443	4,300	5,214	5,649	6,707	7,383	8,508	9,470	22,489	25,275
Reserve & Surplus	3,171	3,992	4,738	4,881	5,798	6,106	7,027	7,832	17,267	19,183
Share Capital	100	100	100	300	300	600	600	600	600	600

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	-94	300	-47	-261	210	165	72	-243	641	-380
Investing Activities	-491	-1,138	-510	-684	-703	-1,505	-3,651	-1,662	-14,260	-1,002
Operating Activities	211	371	640	662	1,155	1,283	1,160	1,177	1,853	2,954
Financing Activities	186	1,068	-178	-240	-242	388	2,564	242	13,049	-2,333

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024
Promoter	60.67 %	60.64 %	60.64 %	60.64 %	60.64 %	60.64 %	60.64 %	60.64 %	60.64 %	60.64 %	60.64 %	60.64 %	60.64 %	60.64 %	60.64 %	60.64 %
FIIs	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	7.96 %	6.55 %	5.63 %	5.90 %	5.93 %	5.66 %
DIIs	6.65 %	6.89 %	6.87 %	6.83 %	7.79 %	7.30 %	7.76 %	8.63 %	11.90 %	12.56 %	14.08 %	14.51 %	13.68 %	14.30 %	14.44 %	15.37 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	10.89 %	11.03 %	11.49 %	11.37 %	10.87 %	10.72 %	12.07 %	12.46 %	13.21 %	13.34 %	13.61 %	14.47 %	15.53 %	14.63 %	14.57 %	14.07 %
Others	21.79 %	21.44 %	21.00 %	21.16 %	20.70 %	21.35 %	19.54 %	18.27 %	14.26 %	13.46 %	3.70 %	3.83 %	4.52 %	4.53 %	4.42 %	4.27 %
No of Share Holders	0	3,11,349	3,38,815	3,63,447	3,64,502	3,47,911	3,41,016	3,69,816	4,11,086	4,12,441	4,15,046	4,34,339	4,70,261	4,43,513	4,39,503	4,27,705